[PRESS RELEASE] – LONG BEACH, Calif., and TORONTO, June 25, 2026 – Glass House Brands Inc. announced that its subordinate voting shares have been approved for listing on the New York Stock Exchange (NYSE).
“We are proud and excited to be listing on the NYSE, the world’s most prestigious and important stock exchange,” Glass House co-founder, Chairman and CEO Kyle Kazan said. “This listing was not possible prior to the recent reclassification of medical cannabis to Schedule III and represents an important developmental milestone for Glass House, the cannabis industry overall and our valued long-term shareholders who have supported us since inception.
“Beyond the listing, we remain encouraged by the opportunities presented by rescheduling. As a leading producer of low-cost, sought-after cannabis, Glass House is uniquely positioned to benefit potential near-term opportunities presented, including the opening of interstate commerce and export of medical cannabis to Europe, each of which would meaningfully increase our addressable market size and unlock enhanced profit and cash flow generation driven by more favorable pricing dynamics.”
The subordinate voting shares are expected to begin trading under the symbol “GLAS” at the opening of trading on June 30, 2026.
The company anticipates that subordinate voting shares will continue trading on the OTCQX under the symbol “GLASF” until the close of market on June 29, 2026. The subordinate voting shares will continue to trade on CBOE under the symbol “GLAS.A.U”.
Current shareholders of the company are not required to take any action prior to the company’s expected listing.
